-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Approves First CAR T-Cell Therapy For Marginal Zone Lymphoma In The US; Approved A New Indication For Breyanzi

Benzinga·12/04/2025 22:07:25
Listen to the news